Related Experiment Video
Updated: Jun 3, 2026
07:56
A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
Synuclein modulation of monoamine transporters
1Department of Biochemistry, Molecular, Cellular Biology and Lombardi Cancer Center, Georgetown University, Washington, DC 20007, United States.
FEBS Letters
|March 15, 2011
Summary
Synuclein proteins (alpha-synuclein, beta-synuclein, gamma-synuclein) regulate monoamine transporter function. This finding is crucial for understanding neurotransmitter homeostasis and mood disorders.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Synuclein proteins' biological function is not fully understood, despite their association with neurodegenerative diseases.
- Emerging evidence suggests a role for synucleins in maintaining the balance of monoamine neurotransmitters.
Purpose of the Study:
- To elucidate the biological function of synuclein proteins.
- To investigate the role of synucleins in monoamine neurotransmitter homeostasis and transporter regulation.
Main Methods:
- Investigated interactions between synucleins (α-synuclein, β-synuclein, γ-synuclein) and key monoamine transporters (dopamine, norepinephrine, serotonin transporters).
- Examined the influence of synucleins on transporter trafficking, cell surface expression, and function.
- Analyzed the role of neuronal cytoskeleton and pre-synaptic scaffolding proteins in synuclein-transporter interactions.
Main Results:
- Synucleins modulate the trafficking and cell surface expression of dopamine, norepinephrine, and serotonin transporters.
- Synuclein interactions with transporters, cytoskeleton, and scaffolding proteins are central to regulating monoamine re-uptake.
- This modulation impacts overall monoamine neurotransmission.
Conclusions:
- Synuclein proteins play a critical role in regulating monoamine transporter function and neurotransmitter homeostasis.
- Understanding synuclein-transporter interactions offers insights into the pathophysiology of mood disorders and potential therapeutic targets.
More Related Videos
Related Concept Videos
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:45Regulation of Nuclear Protein Sorting
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...